Related references
Note: Only part of the references are listed.α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
A NOVEL α-SYNUCLEIN MISSENSE MUTATION IN PARKINSON DISEASE
Christos Proukakis et al.
NEUROLOGY (2013)
Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity
Meret Nora Gaugler et al.
ACTA NEUROPATHOLOGICA (2012)
Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies
Lih-Fen Lue et al.
BRAIN PATHOLOGY (2012)
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
Jacqueline Burre et al.
JOURNAL OF NEUROSCIENCE (2012)
Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons
Ayse Ulusoy et al.
NEUROBIOLOGY OF DISEASE (2012)
Use of viral vectors to create animal models for Parkinson's disease
Karin Loew et al.
NEUROBIOLOGY OF DISEASE (2012)
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
M. Decressac et al.
NEUROBIOLOGY OF DISEASE (2012)
Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9
A. Van der Perren et al.
GENE THERAPY (2011)
Modelling of Parkinson's disease in mice
Marie-Francoise Chesselet et al.
LANCET NEUROLOGY (2011)
Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
James B. Koprich et al.
PLOS ONE (2011)
Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at Scale
Martin Lock et al.
HUMAN GENE THERAPY (2010)
α-Synuclein Transgenic Mice Reveal Compensatory Increases in Parkinson's Disease-Associated Proteins DJ-1 and Parkin and Have Enhanced α-Synuclein and PINK1 Levels After Rotenone Treatment
Sonia George et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Inhibition of FK506 Binding Proteins Reduces α-Synuclein Aggregation and Parkinson's Disease-Like Pathology
Melanie Gerard et al.
JOURNAL OF NEUROSCIENCE (2010)
Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
James B. Koprich et al.
MOLECULAR NEURODEGENERATION (2010)
Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
Shuwen Cao et al.
MOLECULAR NEURODEGENERATION (2010)
Comparative Transduction Efficiency of AAV Vector Serotypes 1-6 in the Substantia Nigra and Striatum of the Primate Brain
Eleni A. Markakis et al.
MOLECULAR THERAPY (2010)
Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice
Silke Nuber et al.
NEUROGENETICS (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson's disease
Toru Yasuda et al.
JOURNAL OF NEUROCHEMISTRY (2009)
α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease
Nikolaus R. McFarland et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat
Sharon Reimsnider et al.
MOLECULAR THERAPY (2007)
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain
Jean-Marc Taymans et al.
HUMAN GENE THERAPY (2007)
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
Andisheh Eslamboli et al.
BRAIN (2007)
Non-invasive imaging of neuropathology in a rat model of α-synuclein overexpression
Erwin Lauwers et al.
NEUROBIOLOGY OF AGING (2007)
Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease
Linda Vercammen et al.
MOLECULAR THERAPY (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
C Burger et al.
MOLECULAR THERAPY (2004)
Overexpression of α-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of α-synuclein and activation of caspase-9:: resemblance to pathogenetic changes in Parkinson's disease
M Yamada et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Ubiquitination of α-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function
GK Tofaris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein:: A new primate model of Parkinson's disease
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Overexpression of Parkinson's disease-associated α-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP
ZZ Dong et al.
JOURNAL OF NEUROBIOLOGY (2002)
Characterization of lentiviral vector-mediated gene transfer in adult mouse brain
V Baekelandt et al.
HUMAN GENE THERAPY (2002)
Share Paper
